FormWeb • OHS Infusion Medication Standardization

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

SDS Online Do Not Crush OHS Pharmacy Contact Louisiana Poison Control
(800) 222-1222

Webpage Links

Add Formweb to your mobile device

Android iOS

Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.

Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

Drug	Remote Team AP	On-Site AP	Preferred Storage for AP	Medications that should not be prepared on Friday for Monday AP	HAM Medication	LASA Medication	Vial Size	Do Not Refrigerate	Protect From Light	Filter Requirement	Primary or seconding Tubing	Low-Sorb tubing required	Non-DEHP Container	Do Not Shake	Vesicant / Irritant	Standard IV Fluids	Infusion Concentration	Infusion Time	Diluent to Reconstitute	Room Temp Stability	Stability in Refrigerator	Special Precautions	Overfill	Administration Instructions	References	remainder vials for reuse (6 hours SDV - hood[340B]-NO, but can reject, 28d MDV)	Notes (anything additional you need to know)
ado-trastuzumab emtansine (Kadcyla)	No	No	N/A	N/A	Yes	Yes	160 mg 100 mg	N/A	NO	In-Line Filter 0.2 - 0.22 micron	Secondary	NO	NO	Do Not Shake	Irritant with vesicant-like properties	250 mL NS	N/A	Loading dose: 90 min. Subsequent dose: 30 min.	100 mg vial + 5 mL SWI or 160 mg vial + 8 mL SWI (Conc: 20 mg/mL)	Use immediately at RT	24 hrs	DO NOT SHAKE Swirl gently until dissolved/gently invert bag to mix. Do not use if discolored or visible particles present Incompatible in D5W.	Add drug into bag (overfill + drug volume)	Infuse over 90 minutes for first infusion, 30 minutes for subsequent infusion if first dose well tolerated. Do not give as IV push or bolus. Monitor pt for infusion reactions.	1, 8	SDV	Reconstitution instructions say "add" to infusion bag containing NS 250 ml.
alemtuzumab (Campath)	No	No	N/A	N/A	Yes	No	30 mg/mL	N/A	Protect vials and dilution from light	NO	Secondary	NO	NO	Do Not Shake	NO	100 mL NS or D5W	N/A	2 hrs	30 mg/mL Solution: for the 3 mg and 10 mg dose, use 1 ml syringe calibrated in increments of 0.01 ml. For the 30 mg dose, use 1 ml or 3 ml syringe calibrated in 0.1 ml	Use within 8 hrs of dilution.	Use within 8 hrs of dilution.	Gently invert the bag to mix the solution. Use 1 mL or 3 mL syringe.	Add drug into bag (overfill + drug volume)	IV infusion over 2 hours. Do not give as IV push or bolus.	1, 3, 8	SDV
alemtuzumab (Lemtrada) Commercially available for MS	No	No	N/A	N/A	Yes	No	12 mg/1.2 mL (10 mg/mL)	N/A	Protect vials and dilution from light	NO	Secondary	NO	NO	Do Not Shake	NO	100 mL NS or D5W	N/A	4 hrs	10 mg/mL Solution	Use within 8 hrs of dilution.	Use within 8 hrs of dilution.	Gently invert the bag to mix the solution.	N/A	IV infusion over 4 hours. Do not give as IV push or bolus.	1, 8	SDV
arsenic trioxide (Trisenox)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	No	12 mg/6 mL (2 mg/mL) - preferred OR 10 mg/10 mL (1 mg/mL)	N/A	NO	NO	Secondary	NO	NO	N/A	NO	100 - 250 mL NS or D5W	N/A	1-2 hrs	2 mg/mL Solution OR 1mg/mL Solution	24 hrs	48 hrs	Filter the drug before dilution with 5 micron filter needle if medication in ampule.	Add drug into bag (overfill + drug volume)	Infusion duration may be extended up to 4 hours if acute vasomotor reactions are observed	1, 8	SDV	Note multiple concentrations exist, verify product prior to verifying and mixing.
azaCITIDine IV (Vidaza)	No	No	N/A	N/A	Yes	Yes	100 mg	Do not refrigerate; use immediately	NO	NO	Secondary	NO	NO	N/A	NO	IV: 50 - 100 mL NS	For Peds: 0.9-4 mg/mL	IVPB: 10-40 min	IV: 10 mL SWFI (10 mg/mL) when diluted in NS	Must be completed within 1 hr of reconstitution	N/A	Shake or roll vial until solution is dissolved and clear. Very limited stability and must be prepared immediately prior to each dose. Incompatible with dextrose.	Add drug into bag (overfill + drug volume)	Infuse over 10-40 minutes and complete within 1 hour of reconstitution.	1, 8	SDV	IVPB
azaCITIDine SUBQ (Vidaza)	No	No	N/A	N/A	Yes	Yes	100 mg	N/A	NO	DO NOT FILTER	N/A	N/A	N/A	N/A	N/A	N/A	SQ: Divide dose >4 mL equally into 2 syringes	N/A	SUBQ: 4 mL SWFI (25 mg/mL)	1 hr after reconstitution	8 hrs	Slowly add 4 mL SWFI to each vial. Vigorously shake or roll vial until suspension forms (will be cloudy). Divide doses requiring more than 1 vial. Do not filter after reconstitution. If removed from refrigerator, suspension may be allowed to equilibrate at RT for 30 minutes prior to administration.	No (syringe)	Resuspend contents of syringe by vigorously rolling between palms immediately prior to administration. Rotate injection sites. Sites should be 1 inch from previous sites. Don't administer in bruised or reddened areas.	1, 8	SDV	Dispensed in a syringe.
BCG (Tice BCG)	No	No	N/A	N/A	Yes	No	50 mg	N/A	Protect from light; wrap syringe in brown bag	DO NOT FILTER	N/A	N/A	50mL syringe	Do Not Shake	N/A	TV 50 mL PF NS (Intravesicular only)	N/A	N/A	Reconstitute with 1 mL sterile PF saline using a 3 mL syringe. Add to vial, swirl gently to form suspension	2 hrs	2 hrs	Clean with bleach. Irrigation only. Avoid cross-contamination. Handle carefully - biohazard.	No (syringe)	Intravesical	1, 8	SDV	Dispensed in a syringe.
Belantamab Mafodotin-blmf (Blenrep)					Yes	No	100 mg	N/A	NO	0.2 micron filter may be used	Secondary	NO	NO	Do Not Shake	NO	250 mL NS	0.2-2 mg/ml	30 minutes	Reconstitute with 2 ml SWFI (Conc: 50 mg/ml)	After removal from refrigerator, administer within 6 hours including infusion time.	24 hours	Prior to reconstitution, remove vials from refrigerator and allow to stand at RT for 10 minutes. Gently swirl and do not shake. Discard if particulate is present. Diluted solution should be clear and colorless.	Add drug into bag (overfill + drug volume)	If refrigerated, allow to equilibrate prior to administration. Infuse over 30 minutes using a PVC or PO infusion set. Filtration not required. If filtered, use 0.22 micron PES filter.	1, 8	SDV	REMs requirements.
belinostat (Beleodaq)	No	No	N/A	N/A	Yes	No	500 mg	Do not refrigerate	NO	0.22 micron inline filter	Secondary	NO	NO	N/A	NO	250 ml NS	N/A	30 minutes	Reconstitute with 9 mL SWFI (Conc: 50 mg/mL)	Solutions diluted for infusion in NS may be stored up to 36 hours at RT including infusion time	N/A	Swirl vial contents until there are no visible particles in the reconstituted solution. Do not use if cloudy or precipitate is present.	Add drug into bag (overfill + drug volume)	Infuse over 30 minutes using a 0.22 micron inline filter. Increase infusion time to 45 minutes if pain or other signs and symptoms occur.	1, 8	SDV
bendamustine (Bendeka)	No	No	N/A	N/A	Yes	No	100 mg (25 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant with vesicant-like properties	50 mL NS or D5W	0.49-5.6 mg/mL	10 min	25 mg/mL Solution	NS: 6 hrs D5W: 3 hrs Infusion must be completed within this time	24 hrs Infusion must be completed within this time	Allow the vial to reach room temperature prior to use. Do not use if particulate observed after reaching RT. Store intact vials and vials reconstituted for solution in original carton. Partially used vials are stable for up to 28 days. Do no withdraw more than 6 doses from each vial.	Add drug into bag (overfill + drug volume)	Infuse over 10 minutes. Administration times for off-label uses/doses vary by protocol.	1, 8	MDV	Note formulation.
bendamustine (Belrapzo)	No	No	N/A	N/A	Yes	No	100 mg (25 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant with vesicant-like properties	500 mL NS	0.05-0.7 mg/mL	CLL: 30 minutes NHL: 60 minutes	25 mg/mL Solution	3 hours (including infusion time)	24 hours (including infusion time)	Allow the vial to reach room temperature prior to use. Do not use if particulate observed after reaching RT. Store intact vials and vials reconstituted for solution in original carton. Partially used vials are stable for up to 28 days. Do no withdraw more than 6 doses from each vial.	Add drug into bag (overfill + drug volume)	Infusion varies with diagnosis. For CLL - infuse over 30 minutes. For NHL - infuse over 60 minutes.	1,8	MDV	Note formulation.
Bendamustine (TREANDA)							180 mg/2ml (90 mg/ml)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant with vesicant-like properties	500 ml NS	0.2 to 0.7 mg/ml	CLL: 30 minutes NHL: 60 minutes	90 mg/ml Solution	2 hours (including infusion time)	24 hrs	Do not combine Treanda formulations. Check compatibility with CSTD. If using a syringe to withdraw and transfer Treanda injection from the vial into the infusion bag, only use a polypropylene syringe and metal needle with a polypropylene hub. Admixture should be clear.	Add drug into bag (overfill + drug volume)	Infusion varies with diagnosis. For CLL - infuse over 30 minutes. For NHL - infuse over 60 minutes.	1.8	SDV	Note formulation.
Bendamustine (TREANDA)							100 mg 25 mg	N/A	Protect vials from light	NO	secondary	NO	NO	N/A	Irritant with vesicant-like properties	500 ml NS	0.2 to 0.6 mg/ml	CLL: 30 minutes NHL: 60 minutes	25 mg vial: 5 ml SWFI 100 mg vial: 20 ml SWFI (Conc: 5 mg/ml) Transfer to infusion bag within 30 minutes	3 hours (including infusion time)	24 hrs	Do not combine Treanda formulations.	Add drug into bag (overfill + drug volume)		1.8	SDV	Note formulation.
bleomycin IV (Blenoxane)	No	No	N/A	N/A	Yes	No	15 units 30 units	N/A	NO	NO	Secondary	NO	NO	N/A	Irritant	100 mL NS PEDs: 50 mL NS CI : 1000 mL NS	0.015 units/mL - 3 units/mL	IVPB: 10 minutes CI: 24 hrs	15 unit vial + 5 mL NS 30 unit vial +10 mL NS (conc: 3 units/mL)	24 hrs	N/A	D5W is not recommended	Add drug into bag (overfill + drug volume)	IV does should be administered slowly over 10 minutes.	1, 3, 4, 8	SDV
bleomycin IM/SUBQ (Blenoxane)	No	No	N/A	N/A	Yes	No	15 units 30 units	N/A	NO	NO	N/A	N/A	NO	N/A	N/A	N/A	3-15 units/mL	N/A	15 unit vial: 1 mL SWFI 30 unit vial: 2 mL SWFI (conc: 15 units/mL)	24 hrs	N/A	D5W is not recommended	No (syringe)	May cause pain at injection site.	1, 3, 4, 8	SDV	Dispensed in a syringe.
bleomycin Intrapleural (Blenoxane)	No	No	N/A	N/A	Yes	No	15 units 30 units	N/A	NO	NO	N/A	N/A	NO	N/A	N/A	Intrapleural: 50 ml NS	N/A	N/A	60 units in 50-100 mL sodium chloride for injection.	24 hrs	N/A	D5W is not recommended	No	60 units in 50 to 100 mL NS; use of topical anesthetics or opioid analgesia is usually not necessary.	1, 3, 4, 8	SDV	Dispensed in a syringe.
blinatumomab (Blincyto)	No	No	N/A	N/A	Yes	No	35 mcg	Okay to refrigerate	Protect vials from light	0.2 micron in-line filter ONLY for 24-hour and 48-hour bag; NO filter needed for 7-day bag	NO for hospital bags; pump tubing required for ambulatory pumps -- prime line with active drug solution	YES for hospital bags; not necessary for ambulatory pumps	Non-DEHP Container	Do Not Shake	N/A	24-hour or 48-hour prep: 270 mL-NS 7-dayprep: 90mL bacteriostatic NS	12.5 mcg/mL	24 hours OR 48 hours OR 168 hours	See reconstitution tables in package insert	Preservative-Free = 48 hours Preservative = 7 days	Preservative-Free = 8 days Preservative = 14 days	Do not reconstitute blincyto vial with IV solution stabilizer. PRIME THE IV TUBING WITH THE PREPARED SOLUTION (DO NOT PRIME WITH JUST NS). Remove air from the final product (especially for ambulatory infusion pumps).	ERx built to include all pertinent factors in order to have set administration rates per PI	Infusion rates are set (and should not be modified) based off dosing and days needed. There will be residual drug left over after each infusion; this is to ensure the full dose was given. Do not flush the blincyto infusion line, especially when change infusion bags. Flushing lines can result in excess dosage and complications thereof.	1, 8
bortezomib IV (Velcade)	Yes	No	Refrigerated	N/A	Yes	No	3.5 mg	Okay to refrigerate	Protect vials from light	NO	NO	NO	NO	N/A	Irritant	NS only	IV Push: 1 mg/mL	IV Push: 3-5 seconds	IV: 3.5 mL NS (Conc:1 mg/mL)	8 hrs	5 days	Reconstituted product should be a clear and colorless solution. Doses should be given 72 hrs apart. FATAL IF GIVEN INTRATHECALLY.	No (syringe)	Administer via rapid IV push over 3-5 second	1, 2, 3, 5, 8	SDV	Dispensed in a syringe.
bortezomib SUBQ (Velcade)	No	No	N/A	N/A	Yes	No	3.5 mg	Okay to refrigerate	Protect vials from light	NO	N/A	N/A	NO	N/A	N/A	N/A	SQ Inj: 2.5 mg/mL	N/A	SQ: 1.4 mL NS (Conc: 2.5 mg/mL)	8 hrs	Syringe: 24 hours	Reconstituted product should be a clear and colorless solution. Doses should be given 72 hrs apart. FATAL IF GIVEN INTRATHECALLY.	No (syringe)	Not all bortezomib products are approved for subq administration.	1, 2, 3, 5, 8	SDV	Dispensed in a syringe.
brentuximab vedotin (Adcetris)	No	No	N/A	N/A	Yes	No	50 mg	N/A	Protect vials from light	NO	NO	NO	NO	Do Not Shake	NO	100 mL NS or D5W	0.4 - 1.8 mg/mL	30 min	50 mg vial + 10.5 mL SWFI (Conc: 5 mg/mL)	Use immediately at RT	24 hrs	Direct the stream toward the wall of vial, not directly at the cake or powder. Gently swirl the vial to aid dissolution. The reconstituted solution should be clear, colorless, and free of particles	Add drug into bag (overfill + drug volume)	Infuse over 30 minutes. Do not administer as IV push or bolus.	1, 8	SDV
busulfan (Busulfex)	No	No	N/A	N/A	Yes	No	60 mg/10 ml (6 mg/ml)	N/A	NO	NO	NO	NO	NO	Mix by inversion	Irritant	NS or D5W Dilution volume should be 10 times the volume of busulfan injection	Approx 0.5 mg/mL	2 hrs (Central Line)	6 mg/mL Solution	8 hrs including infusion time	12 hrs including infusion time	Always add Busulfex to diluent, not the diluent to Busulfex. Mix thoroughly by inverting several times. Incompatible with polycarbonate containing syringes, filters, or IV tubing. Verify compatibility with CSTD. Do not use vial if particulate matter is present.	ERx is set to calculate 1:10 drug volume: diluent volume to hit concentration of 0.54 mg/mL	Infuse dose over two hours. Flush indwelling catheter with approximately 5 ml NS or D5W before and after infusion.	1, 8	SDV
cabazitaxel (Jevtana)	No	No	N/A	N/A	Yes	No	60 mg	Do not refrigerate vials. Drug diluted for infusion may be refrigerated	NO	0.22 micron inline filter	Primary	YES	Non-DEHP Container	Do Not Shake	NO	250 mL NS or D5W Larger vol if dose > 65 mg	0.1 - 0.26 mg/mL	1 hr	60 mg vial + all of supplied diluent (Conc: 10 mg/mL) (Use within 30 min)	8 hrs	24 hrs	Direct diluent toward the wall of vial to limit foaming. Thoroughly mix by gently inverting the bottle or bag. Do not use if crystallization forms.	Add drug into bag (overfill + drug volume)	Infuse over 1 hour using a 0.22 micron inline filter. Do not use polyurethane containing infusion sets for administration. Allow to reach room temperature prior to infusion.	1, 8	SDV
CARBOplatin (Paraplatin)	Yes (Do not include desensitization)	No	Room Temperature	Do Not Prep on Friday	Yes	Yes	50 mg 150mg 450 mg 600 mg 1000 mg (10 mg/mL)	Do not refrigerate	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant	100 - 250 mL NS or D5W	May be diluted as low as 0.5 mg/mL	≥15 min	10 mg/mL Solution	24 hrs	N/A	Needles or IV administration sets that contain aluminum should not be used in the preparation or administration of carboplatin due to potential precipitate and loss of potency.	Add drug into bag (overfill + drug volume)	Infuse over at least 15 minutes; usually infused over 15 to 60 minutes. Some protocols may require infusions up to 24 hours.	1, 2, 4, 8, 12	MDV	No preservative, manufacturer recommends use within 8 hours
carfilzomib (Kyprolis)	No	No	N/A	N/A	Yes	No	10 mg 30 mg 60 mg	N/A	Protect vials from light	NO	Secondary	NO	NO	Do Not Shake	NO	Dose ≤ 60 mg: 50 mL D5W Dose > 60 mg: 100 mL D5W	N/A	10-30 min	10 mg vial + 5 mL SWFI 30 mg vial + 15 mL SWFI 60 mg vial + 29 mL SWFI (Conc: 2 mg/mL)	4 hrs	24 hrs	Direct diluent toward the wall of vial to limit foaming. Gently swirl/invert vial for 1 min or complete dissolution. DO NOT SHAKE. If foaming occurs, allow solution to rest for 2-5 min.	Add drug into bag (overfill + drug volume)	Administer over 10-30 minutes depending on the regimen. Flush line immediately before and after infusion with NS or D5W	1, 8	SDV	Reconstitution instructions mention use of needle vs CSTD
carmustine (BiCNU)	No	No	N/A	N/A	Yes	No	100 mg	N/A	Protect from light	NO	Primary	YES	Non-DEHP Container	N/A	Irritant	500 mL NS or D5W	Final minimum concentration = 0.2 mg/mL	2 hrs	100 mg vial + 3 mL supplied alcohol, then + 27 mL SWFI (Conc: 3.3 mg/mL)	8 hrs	24 hrs, followed by additional 6 hours at room temperature.	High-dose carmustine (transplant dose): Infuse over at least 2 hours to avoid excessive flushing, agitation, and hypotension. High-dose carmustine may be fatal if not followed by stem cell rescue.	ERx set to 1:1 drug/volume	Infuse over at least 2 hours through a free-flowing saline or dextrose infusion. Administer through a central catheter to alleviate venous pain/irritation. Do not exceed a rate of 1.66 mg/m2/minute.	1, 4, 8, 18	SDV	Per Micromedex compatibility with NS - concentrations up to 1mg/mL when compounded in polyethylene-lined bags, at room temperature, found carmustine losses of 10% at the 3 hours mark. Per Micromedex compatibility with D5W - concentrations up to 1mg/mL when compounded in polyolefin plastic bags, at room temperature, found carmustine remained 96% intact at the 4 hours mark. Because of this data, OHS stem cell transplant sites agree on standardizing to mixing in D5W, at a maximum concentration of 1mg/mL, and should be prepared as close to administration as possible.
cidofovir (Vistide)	No	No	N/A	N/A	No	No	75 mg/mL	N/A	NO	NO	Secondary	NO	NO	N/A	NO	100 mL NS	N/A	1 hour	75 mg/mL Solution	Immediate use	24 hrs including administration time	Dilute dose in 100 mL prior to infusion.	N/A	For IV infusion only. Infuse over 1 hour.	1, 8	SDV
CISplatin (Platinol)	Yes	No	Room Temperature	N/A	Yes	Yes	50 mg 100 mg 200 mg (1 mg/mL)	Do Not Refrigerate	Protect vials from light	NO	Secondary	NO	NO	N/A	Vesicant (> 0.5 mg/mL)	100 - 2000 mL NS PEDs: Per Protocol	N/A	≥15 min CI: 24 hrs (Max: 1 mg/min)	1 mg/mL Solution	4 days	N/A	Do not use with aluminum containing needles.	Add drug into bag (overfill + drug volume) If goes over maximum volume allowance, manipulate during verification to just overfill only	Has been infused over 30 minutes to 4 hours, at a rate of 1 mg/minute or as a continuous infusion. Refer to protocol.	1, 2, 4, 8	MDV	Could potentially be a problem with the overfill amount
Cladribine (Leustatin)	No	No	N/A	N/A	Yes	No	10 mg/10 mL (1 mg/mL)	N/A	Protect vials from light	Filter prior to dilution	Secondary	NO	NO	N/A	Irritant	500 mL NS	N/A	24 hrs Other infusion times per protocol	1 mg/mL Solution Filter through 0.22 micron syringe filter prior to dilution	24 hours in PVC container	May be stored for up to 8 hours prior to infusion	Filter through 0.22 micron syringe filter prior to further dilution. D5W is not recommended	Add drug into bag (overfill + drug volume)	Usually administered over continuous infusion or over 2 hours; infusions over 3 hours have also been reported.	1, 8	SDV	A precipitate my develop at lower temps. May be resolubilized at RT or by vigorous shaking
CLOFarabine (Clolar)	No	No	N/A	N/A	Yes	Yes	20 mg/20 mL (1 mg/mL)	Do Not Refrigerate	NO	Filter prior to dilution	Secondary	NO	NO	N/A	NO	NS or D5W	0.15 - 0.4 mg/mL	2 hrs	1 mg/mL Solution Filter through 0.22 micron syringe filter prior to further dilution	24 hrs	N/A	Filter through 0.22 micron syringe filter prior to further dilution.	Add drug into bag (overfill + drug volume)	Infuse over 2 hours for relapsed/refractory ALL. May be infused over 1 hour (off-label). Continuous IV fluids are encouraged to decrease adverse events and tumor lysis.	1, 3, 8	SDV
cyclophosphamide (Cytoxan)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	Yes	500 mg 1000 mg 2000 mg	N/A	NO	NO	Secondary	NO	NO	N/A	Irritant	D5W or NS	D5W: Minimum concentration of 2 mg/mL NS: 0.24 mg/mL to 10 mg/mL 20 mg/mL for direct injection	Varies with protocol	500 mg vial + 25 mL SWFI or NS 1000 mg vial + 50 mL SWFI or NS 2000 mg vial + 100 mL SWFI or NS (Conc: 20 mg/mL)	24 hrs	48 hrs	Direct injection: reconstitute with NS only.	Add drug into bag (overfill + drug volume)	Infusion rate varies with protocol.	1, 3, 4, 8	SDV	Note differing products. One option is straight drug in a syringe
cyclophosphamide (Cytoxan)	Yes	No	Refrigerated	N/A	Yes	Yes	500 mg/2.5 mL 1000 mg/5 mL 2000 mg/10 mL (200 mg/mL)	N/A	NO	NO	Secondary	NO	NO	N/A	Irritant	D5W or NS	2 mg/mL to 20 mg/mL for direct injection	Varies with protocol	200 mg/mL solution	24 hrs	6 days	Contains Alcohol, Do not use sterile water for direct injection.	Add drug into bag (overfill + drug volume) If goes over maximum volume allowance, manipulate during verification to just overfill only	Infusion rate varies with protocol.	1, 8	MDV	Note differing products. One option is straight drug in a syringe
CYTarabine (Ara-C, Cytosar)	Yes	No	Refrigerated	Do not Prep on Friday for IT and IV syringe	Yes	Yes	100 mg/5 mL PF (20 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	NO	250-1000 mL NS or D5W PEDs: Per Protocol	Max 100 mg/mL for subcutaneous infusion	IV Push: over 15-30 minutes. IVPB: 1-3 hours CI over 12-24 hrs.	20 mg/mL PF Solution	24 hrs IT: 4 hrs IV Syringe: 24 hrs	7 days IT: N/A IV Syringe: 24 hrs	Use PF NS for intrathecal preparations. Solutions containing bacteriostatic agents may be used for SubQ and standard doses, BUT not for IT or high-dose therapies	Add drug into bag (overfill + drug volume)	Intrathecal doses should be administered as soon as possible.	1, 2, 3, 4, 8	SDV	Note differing strengths of product
CYTarabine (Ara-C, Cytosar)	Yes	No	Refrigerated	Do not Prep on Friday for IV syringe	Yes	Yes	2000 mg/20 mL PF (100 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	NO	250-1000 mL NS or D5W PEDs: Per Protocol	Max 100 mg/mL for subcutaneous infusion	IV Push: over 15-30 minutes. IVPB: 1-3 hours CI over 12-24 hrs	100 mg/mL PF Solution	24 hrs IV Syringe: 24 hrs	7 days IV Syringe: 24 hrs	Do not use bulk bottle for intrathecal. Solutions containing bacteriostatic agents may be used for SubQ and standard doses, BUT not for IT or high-dose therapies	Add drug into bag (overfill + drug volume)		1, 8	SDV	Note differing strengths of product
dacarbazine (DTIC)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	No	100 mg 200 mg	N/A	Light Protect vials and solution	NO	Secondary	NO	NO	N/A	Irritant	250 mL NS or D5W	N/A	15-60 min	100 mg vial + 9.9 mL SWFI 200 mg vial + 19.7 mL SWFI (Conc: 10 mg/mL)	8 hrs	24 hrs	Too rapid infusion = severe venous irritation.	Add drug into bag (overfill + drug volume)	Infuse over 15-60 minutes. Rapid infusion may cause severe venous irritation.	1, 2, 4, 8	SDV
DACTINomycin (Cosmgen)	No	No	N/A	N/A	Yes	Yes	0.5 mg	Do Not Refrigerate	Light Protected	DO NOT FILTER	Secondary	NO	NO	N/A	Vesicant	50 mL NS or D5W May be injected directly into tubing of running solution	≥ 0.01 mg/mL	IV Push: 5 min IVPB: 10-15 min	0.5 mg vial + 1.1 mL PF SWFI (Conc: 0.5 mg/mL)	4 hrs from reconstitution to completion of infusion	N/A	Very corrosive to soft tissue.	Add drug into bag (overfill + drug volume)	Infuse over 10-15 minutes, may be given slow IVP off label.	1, 4, 10	SDV	No IM or SubQ, may be dispensed in bag or syringe
DAUNOrubicin (Cerubidine)	Yes	No	Room Temperature	Do Not Prep on Friday	Yes	Yes	20 mg/4 mL (5 mg/mL)	N/A	Protect vials and infusion from light	NO	Secondary	NO	NO	N/A	Vesicant	IVPB: 100 mL NS	N/A	IV Push: 5 min IVPB: 15-30 min	5 mg/mL Solution	24 hrs	N/A	Avoid extravasation	Add drug into bag (overfill + drug volume)	Administer as slow IV push into a rapidly flowing IV or as infusion over 15-30 minutes.	1, 4, 10	SDV	No IM or SubQ, may be dispensed in bag or syringe
DAUNOrubicin/ CYTarabine Liposomal (Vyxeos)	No	No	N/A	N/A	Yes	Yes	44 mg daunorubicin/100 mg cytarabine	N/A	Protect vials from light	Not required, but may use >15 micron filter	Secondary	NO	For peds doses diluted in <500 mL	Do Not Shake	May be an irritant	500 mL NS or D5W	N/A	90 minutes	Add 19 ml SWFI. Carefully swirl contents for 5 minutes/gently invert vial very 30 seconds. Let rest for 15 minutes after reconstitution (Conc: 2.2 mg/ml daunorubicin component)	Use immediately at RT	4 hrs	Allow vials to equilibrate to RT for 30 minutes. Gently invert each vial 5 times prior to withdrawing dose. Mix bag by gentle inversion.	Add drug into bag (overfill + drug volume)	Administer over 90 minutes via infusion pump through a central venous catheter	1, 8	SDV	No IM or SubQ. Drug is dosed on daunorubicin component.
decitabine (Dacogen)	No	No	N/A	N/A	Yes	No	50 mg	N/A	NO	NO	Secondary	NO	NO	N/A	NO	50 - 250 mL NS or D5W	0.1 - 1 mg/mL	1-3 hrs	50 mg + 10 mL SWFI (Conc: 5 mg/mL)	Must be used w/in 15 min of reconstitution if added to room temperature solution for infusion	4 hrs using COLD solution for infusion	Use cold solution for infusion	Add drug into bag (overfill + drug volume)	Infuse over 1-3 hours depending on dosing regimen	1, 8	SDV
dexrazoxane Brand (Zinecard)	No	No	N/A	N/A	No	No	500 mg 250 mg	N/A	NO	NO	Secondary	NO	NO	N/A	NO	LR	1.3 - 3 mg/mL	Infuse over 15 minutes	250 mg + 25 mL SWFI 500 mg + 50 mL SWFI (Conc: 10 mg/mL)	1 hr	4 hrs	Do not mix dexrazoxane for injection with other drugs.	N/A	Administer the final diluted solution of dexrazoxane by intravenous infusion over 15 minutes before the administration of doxorubicin. DO NOT ADMINISTER VIA AN INTRAVENOUS PUSH. Administer doxorubicin within 30 minutes after the completion of dexrazoxane for infusion.	1, 8	SDV	Note formulation
dexrazoxane (Generic)	No	No	N/A	N/A	No	No	500 mg 250 mg	N/A	NO	NO	Secondary	NO	NO	N/A	NO	NS or D5W	1.3 - 5 mg/mL	Infuse by slow IV push or rapid drip infusion	250 mg + 25 mL supplied diluent 500 mg + 50 mL supplied diluent (Conc: 10 mg/mL)	6 hrs	6 hrs	Do not mix dexrazoxane for injection with other drugs.	N/A	The reconstituted solution should be given by slow IV push or rapid drip intravenous infusion from a bag. After completing the infusion of dexrazoxane for injection, and prior to a total elapsed time of 30 minutes (from the beginning of the dexrazoxane for injection infusion), the intravenous injection of doxorubicin should be given.	1, 8	SDV	Note formulation
DOCEtaxel (Taxotere)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	Yes	200mg/10 mL 160 mg/8 mL 80 mg/4 mL 20 mg/1mL (20mg/mL)	N/A	Protect from light	NO	Primary PRIME LINE WITH DRUG	YES	Non-DEHP Container	Do Not Shake	Vesicant	250 - 500 mL NS or D5W Intravesical: 37.5 mg in 50 ml NS	0.3 - 0.74 mg/mL	60 min	20 mg/mL Solution	4 days Syringe: 24 hours	7 days Syringe: 24 hours	Multiple concentrations exist. Some formulations contain alcohol. Coring of the rubber stopper is possible.	Add drug into bag (overfill + drug volume)	Infuse over 1 hour through nonsorbing polyethylene lined non DEHP tubing.	1, 3, 4, 8	MDV	Note concentration. Drug may dispensed in bag or syringe.
DOCEtaxel (Taxotere)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	Yes	160 mg/16 mL 80 mg/8 mL 20 mg/2 mL (10mg/mL)	N/A	Protect from light	NO	Primary PRIME LINE WITH DRUG	YES	Non-DEHP Container	Do Not Shake	Vesicant	250 - 500 mL NS or D5W Intravesical: 37.5 mg in 50 ml NS	0.3 - 0.74 mg/mL	60 min	10 mg/mL Solution	4 days Syringe: 24 hours	7 days Syringe: 24 hours	Multiple concentrations exist. Some formulations contain alcohol. Coring of the rubber stopper is possible	Add drug into bag (overfill + drug volume)	Infuse over 1 hour through nonsorbing polyethylene lined non DEHP tubing.	1, 3, 4, 8	MDV	Note concentration. Drug may dispensed in bag or syringe.
DOXOrubicin (Adriamycin)	Yes	No	Room Temperature	Do Not Prep on Friday	Yes	Yes	200 mg/100 mL 150 mg/75 mL 50 mg/25 mL 20 mg/10 mL 10 mg/5 mL (2mg/mL)	N/A	Protect vials and dilution from light	NO	Secondary	NO	NO	N/A	Vesicant	50 to 1000 mL D5W or NS	N/A	IV Push: 5 min IVPB: ≥15 min CI: 24 hrs	2 mg/mL Solution	24 hrs	24 hrs		Add drug into bag (overfill + drug volume)	Administer IV push over at least 3 to 10 minutes or by continuous infusion. Do not administer IM or SubQ.	1, 2, 3, 4, 8, 10	SDV	Note formulation. Drug may dispensed in bag or syringe.
DOXOrubicin Liposomal (Doxil)	No	No	N/A	N/A	Yes	Yes	20 mg/ 10 mL 50 mg/25 mL (2mg/mL)	N/A	NO	DO NOT FILTER	Secondary	NO	NO	N/A	Irritant	Dose ≤90 mg: 250 mL D5W Dose >90 mg: 500 mL D5W	Max: 0.36 mg/mL	Titrate per protocol (Initial ≤1 mg/min, then 1 hr)	2 mg/mL Solution	Use immediately at RT	24 hrs	Not compatible with NS. Do not administer IV push.	Add drug into bag (overfill + drug volume)	Initiate first infusion at 1 mg/min. If no reaction, complete then may given over 1 hour	1, 8	SDV	Note formulation.
elotuzumab (Empliciti)	No	No	N/A	N/A	Yes	No	400 mg 300 mg	N/A	Protect vials and dilution from light	0.2-1.2 micrometer low protein-binding	Secondary	NO	NO	Do Not Shake	NO	NS or D5W (not to exceed 5mL/kg of patient weight)	1-6 mg/mL	Titrate per protocol	300 mg vial + 13 mL SWFI (Deliverable volume: 12 mL) 400 mg vial + 17 mL SWFI (Deliverable volume: 16 mL) (Conc: 25 mg/mL)	8 hrs Infusion must be completed within 24 hours of reconstitution	24 hrs Infusion must be completed within 24 hours of reconstitution	Avoid vigorous agitation. DO NOT SHAKE. After reconstitution, allow solution to stand for 5-10 min. Do not use if discolored.	Add drug into bag (overfill + drug volume)	For IV infusion only. Do not administer as IV push or bolus.	1, 8	SDV
enfortumab vedotin (Padcev)	No	No	N/A	N/A	Yes	No	20 mg 30 mg	N/A	Protect from light	NO	Secondary	NO	NO	Do Not Shake	May be an irritant	D5W or NS	0.3 to 4 mg/mL	30 minutes	20 mg vial + 2.3 mL SWFI 30 mg vial + 3.3 mL SWFI (Conc: 10 mg/mL) Slowly swirl vial until contents dissolved. Allow reconstituted vials to settle until bubbles are gone.	Immediate use	8 hrs	Do not administer as IV push or bolus. Gently invert to mix.	Add drug into bag (overfill + drug volume)	Infuse over 30 minutes	1, 8	SDV
epiRUBicin (Ellence)	No	No	N/A	N/A	Yes	Yes	200 mg/100 mL 50 mg/25 mL (2mg/mL)	N/A	Protect from light	NO	Secondary	NO	NO	N/A	Vesicant	50 - 100 mL NS IVP into tubing of freely flowing NS or D5W	Max 2 mg/mL	IV Push: 3-5 min IVPB: 15- 20 min	2 mg/mL Solution	24 hrs	24 hrs	Given through Y-tube or three way stopcock of free flowing NS or D5W. Product may "gel" at refrigerated temperatures, will return to slightly viscous solution at RT.	Add drug into bag (overfill + drug volume)	Infuse over 15-20 minutes or slow IVP. Do not infuse over <3 minutes. Infuse through free-flowing IV.	1, 3, 8, 10, 13	SDV
eriBULin (Halaven)	No	No	N/A	N/A	Yes	Yes	1 mg/2 ml (0.5 mg/ml)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	NO	100 ml NS	N/A	2-5 minutes	0.5 mg/ml Solution	4 hrs	24 hrs		Add drug into bag (overfill + drug volume)	Infuse over 2-5 minutes	1, 8	SDV
etoposide (VP-16)	Yes	No	Room Temperature	Do Not Prep on Friday	Yes	No	1000 mg/50 mL 500 mg/25 mL 100 mg/5 mL (20mg/mL)	N/A	NO	NO	Primary	YES	Non-DEHP Container	Do Not Shake	Irritant	NS or D5W	0.2 - 0.4 mg/mL (see stability section)	30-60 min	20 mg/mL Solution	24 hrs	24 hrs	Monitor closely for precipitation.	Add drug into bag (overfill + drug volume)	Administer standard doses over at least 30-60 minutes to minimize hypotension	1, 3, 4, 8, 15, 16, 18	MDV	Reference 15 - In BMT regimens, 10mg/mL solutions are extremely well tolerated and can be assigned an expiry date not exceeding 5 days when stored either at refrigeration or room temperature. Micromedex IV Compatibility Charts - If compounding concentrations >0.5 mg/mL, refer to charts to determine safety and stability.
etoposide PHOSPHATE (Etopophos)	No	No	N/A	N/A	Yes	No	100 mg	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant	NS or D5W	0.1 - 20 mg/mL	5 min - 3.5 hrs	100 mg vial + 5 mL SWFI (Conc: 20 mg/mL)	24 hrs	24 hrs	Do not administer as an IV bolus over less than 5 minutes	Add drug into bag (overfill + drug volume)	Infuse over 5 minutes to 3.5 hours	1, 8	SDV
fam-trastuzumab deruxtecan (Enhertu)	No	No	N/A	N/A	Yes	No	100 mg	N/A	Light Protect vials and solution	0.2 - 0.22 micron in-line filter	Primary	YES	NO	Do Not Shake	NO	100 mL D5W	N/A	First dose: 90 min. Subsequent dose: 30 min.	100 mg vial + 5 ml SWFI (Conc: 20 mg/mL) Swirl vial gently until completely dissolved.	4 hours including infusion time	24 hours. Allow to come to room temperature prior to infusion.	Do not use NS. Do not administer as IV push or bolus. Gently invert infusion bag to thoroughly mix.	Add drug into bag (overfill + drug volume)	Administer first infusion over 90 minutes. If tolerated, subsequent infusions may given over 30 minutes.	1, 8	SDV
floxuridine (FUDR)	No	No	N/A	N/A	Yes	No	500 mg	N/A	NO	NO	Secondary	NO	NO	N/A	N/A	100 mL NS or D5W for Intra-arterial administration	N/A	Continuous hepatic intra-arterial infusion using an infusion pump	500 mg vial + 5 mL SWFI (Conc: 100 mg/mL)	24 hrs	Reconstituted vials should be stored under refrigeration for not more than 2 weeks	Intra-arterial infusion only	Add drug into bag (overfill + drug volume)	Continuous hepatic intra-arterial infusion using an infusion pump	1, 3, 4, 8	SDV
fludarabine (Fludara)	Yes	No	Room Temperature	Do Not Prep on Friday	Yes	No	50 mg/2 mL (25 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	NO	100 mL or 125 mL NS or D5W	N/A	30 min	25 mg/mL Solution	48 hrs	48 hrs		Add drug into bag (overfill + drug volume)	Manufacturer recommends administering over 30 minutes. Continuous infusions and boluses	1, 2, 4, 8	SDV
fluorouracil (5-FU)	Yes	No	Room Temperature	N/A	Yes	No	5000 mg/100 mL 2500 mg/50 mL 1000 mg/20 mL 500 mg/10 mL (50mg/mL)	Do Not Refrigerate	Protect vials from light	Not required, but may use >15 micron filter	Secondary	NO	NO	N/A	Irritant	NS or D5W	N/A	IV Push: 1-15 min CI: 24 hrs	50 mg/mL Solution	4 days	N/A	May be slightly discolored. Storage at cool temp inc chance of precipitation. Heat and shake to dissolve precipitate.	Overfill not included due to ERx settings for CADD pumps	May be administered by IV bolus or CADD pump	1, 3, 8	SDV, MDV	Dispensed in IVPB, cassette, and syringe
ganciclovir (Cytovene)	No	No	N/A	N/A	No	No	500 mg/250 mL 500 mg/10 mL (50 mg/mL)	N/A	NO	NO	Secondary	NO	NO	N/A	May be an irritant	100 mL NS or D5W	</= 10 mg/mL	60 minutes	50 mg/mL Solution	N/A	24 hours		N/A	Administer by slow IV infusion over at least 1 hour.	1, 8	SDV
gemcitabine (Gemzar)	Yes	No	Room Temperature	Do Not Prep Syringe on Friday	Yes	No	200 mg/5.26 mL 1000 mg/26.3 mL 2000 mg/52.6 mL (38 mg/mL)	Do Not Refrigerate	NO	NO	Secondary	NO	NO	N/A	Irritant	NS	minimum final concentration of 0.1 mg/ml	30 min (Longer infusion for certain protocols)	38 mg/mL Solution	4 days Syringe: 24 hours	N/A		Add drug into bag (overfill + drug volume)	Infuse over 30 minutes. Some protocols call FDR(fixed dose rate) of 10 mg/m2/minute	1, 3, 8	SDV	May be dispensed in a syringe for intravesical
gemtuzumab ozogamicin (Mylotarg)	No	No	N/A	N/A	Yes	No	4.5 mg	N/A	Protect vials and infusion from light	Inline 0.2 micron filter	Secondary PRIME LINE WITH DRUG	NO	NO	Do Not Shake	NO	NS Doses <3.9 mg must be prepared in a syringe. Gently invert to mix.	0.075 mg/mL to 0.234 mg/mL	2 hours	4.5 mg vial + 5 ml SWFI (Conc: 1 mg/mL)	6 hours including preparation and infusion	18 hours including preparation and infusion	Allow vials to come to room temperature prior to reconstitution for approximately 5 minutes. Protect from light during storage, preparation and administration.	Remove overfill and drug volume in order to make total volume of 50 or 100 ml.	Infuse over 2 hours through a 0.2 micorn in-line filter. Protect IV bag from light-during infusion. Infusion line does not need protected from light. Do not administer as IV push or bolus	1, 8	SDV	May be dispensed in a syringe or as IVPB
IDArubicin (Idamycin)	No	No	N/A	N/A	Yes	Yes	20 mg/20 mL 10 mg/mL 5 mg/mL (1mg/1mL)	N/A	Protect from light	NO	Secondary	NO	NO	N/A	Vesicant	Into tubing of freely flowing NS or D5W	N/A	10-15 min	1 mg/mL Solution	24 hrs	24 hrs	Slightly hazy solution = normal	Add drug into bag (overfill + drug volume)	For IV admin only. Do not administer IM or SubQ. Administer as slow injection over 10-15 minutes into a free-flowing IV.	1, 3, 4, 8	SDV	Dispensed in a syringe, possibly an IVPB as well.
ifosfamide (Ifex)	Yes	No	Refrigerated	N/A	Yes	No	3000 mg 1000 mg	Do Not Refrigerate	NO	NO	Secondary	NO	NO	N/A	Irritant	NS or D5W	0.6 - 20 mg/mL	≥30 min CI: 24 hrs	3000 mg vial + 60 mL SWFI 1000 mg vial + 20 mL SWFI (Conc: 50 mg/mL)	24hrs +/- mesna	7 days with mesna: No data	Powder products only	Add drug into bag (overfill + drug volume) If goes over maximum volume allowance, manipulate during verification to just overfill only	Administer IV over at least 30 minutes. Infusion times may vary with protocol.	1, 2, 3, 4, 8	SDV
inotuzumab ozogamicin (Besponsa)	No	No	N/A	N/A	Yes	No	0.9 mg	N/A	Protect vials and infusion from light	NO	Secondary	NO	NO	Do Not Shake	NO	TV of 50 ml NS	N/A	1 hour	0.9 mg vial + 4 mL SWFI (0.25 mg/ml) Gently swirl to dissolve	4 hrs	3 hrs	Maximum time from reconstitution to the end of the infusion should be </= 8 hours. Refrigerated solutions should be allowed to reach RT ~ 1 hour prior to administration. Gently invert container to mix	Remove overfill and drug volume in order to make TV of 50 mL.	Infuse over 1 hour at a rate of 50 ml/hr	1, 8	SDV
isatuximab (Sarclisa)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	No	500 mg/25 mL 100 mg/ 5 mL (20 mg/mL)	N/A	Protect vials from light	0.22 micron in-line filter	Secondary	NO	NO	Do Not Shake	NO	250 ml NS or D5W (total volume)	N/A	Titration	20 mg/mL Solution	5 hrs	45 hrs, followed by 5 hrs including infusion time at room temperature	Gently homogenize the diluted solution by inverting the bag.	Remove drug volume from bag before adding drug (overfill only)	Administer as an IV infusion.	1, 8	SDV
irinotecan (Camptosar)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	No	300 mg/15 mL 100 mg/ 5 mL 40 mg/mL (20 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant	250 - 500 mL D5W	0.12 - 2.8 mg/mL	90 min	20 mg/mL Solution	24 hrs	48 hrs	D5W preferred (NS = precipitation)	Add drug into bag (overfill + drug volume)	Administer by IV infusion over 90 minutes. Some peds protocols give over 1 hour.	1, 3, 4, 8	SDV
irinotecan liposome (Onivyde)	No	No	N/A	N/A	Yes	No	43 mg/10 mL (4.3 mg/mL)	N/A	Protect from light	DO NOT FILTER	Secondary	NO	NO	Do Not Shake	NO	500 mL NS or D5W	N/A	90 min	4.3 mg/mL Solution	4 hrs	24 hrs	Mix diluted solution by gentle inversion. Allow diluted solution to come to RT prior to admin.	Add drug into bag (overfill + drug volume)	Administer by IV infusion over 90 minutes	1, 8	SDV
ixabepilone (Ixempra Kit)	No	No	N/A	N/A	Yes	No	45 mg 15 mg	Do Not Refrigerate	Protect vials from light	in-line 0.2 micron	Primary	YES	Non-DEHP Container	Do Not Shake	Irritant	LR	0.2 - 0.6 mg/mL	3 hrs	15 mg + 8 mL of supplied diluent 45 mg + 23.5 mL of supplied diluent (Conc: 2 mg/mL)	6 hrs including infusion time	N/A	Allow vials to stand at room temperature for 30 mins prior to preparation; precipitate will dissolve as the vial warms to RT. Gently swirl and invert vial until completely dissolved.	Add drug into bag (overfill + drug volume)	Infuse over 3 hours	1, 8	SDV
loncastuximab tesirine (Zynlonta)	No	No	N/A	N/A	Yes	No	10 mg	N/A	Protect vials from light	0.2-0.22 micron	Secondary	NO	NO	Do not Shake	Irritant with vesicant-like properties	50 mL D5W	N/A	30 minutes	10 mg vial + 2.2 mL SWFI (Conc: 5 mg/ml)	8 hrs	24 hrs	Inject diluent for reconstitution toward the inside wall of vial. Swirl the vial gently until the powder is completely dissolved.	Add drug into bag (overfill + drug volume)	Infuse over 30 minutes	1, 8	SDV	Reconstitution instructions say "add" to infusion bag containing D5W 50 ml.
lurbinectedin (Zepzelca)	No	No	N/A	N/A	Yes	No	4 mg	N/A	NO	NO	Secondary	YES	Non-DEHP Container	NO	Vesicant	250 mL NS or D5W	N/A	60 minutes	4 mg vial + 8 mL SWFI (Conc: 0.5 mg/mL)	24 hours including infusion time	24 hours including infusion time		Add drug into bag (overfill + drug volume)	Infuse over 60 minutes	1, 8	SDV
melphalan (Alkeran)	No	No	N/A	N/A	Yes	No	50mg	Do Not Refrigerate	NO	NO	Secondary	NO	NO	NO	Vesicant	NS	BMT: 2 mg/mL Non-BMT: 0.1 - 0.45 mg/mL	15 min	50mg vial + 10 mL supplied diluent (Conc: 5 mg/mL)	Complete w/in 1 hr of reconstitution	N/A	Reconstitute by rapidly injecting 10 mL of supplied diluent directly into the vial and immediately shake vial vigorously until clear solution is obtained. Prepare as close to the administration time as possible (less than 15 minutes preparation and delivery time).	Add drug into bag (overfill + drug volume)	Infusion over 15 minutes	1, 18		Propylene-glycol based melphalan 2mg/mL was stable in NS for 2 hours at room temperature and for 4 hours refrigerated at 4 degrees Celsius. A precipitate formed after 6 hours under refrigeration.
melphlalan (Evomela)	No	No	N/A	N/A	Yes	No	50mg	Do Not Refrigerate	NO	NO	Secondary	NO	NO	NO	Vesicant	NS	Max 2 mg/mL	30 min	5 mg/mL	Stable for 4 hours at room temperature plus the 1 hour following reconstitution	24 hrs	Use NS solution (8.6mL as directed) to reconstitute Evomela.	Remove drug volume and overfill in order to make total volume of 500mL	Infusion over 30 minutes	1, 18		Captisol-enabled melphalan 2mg/mL was stable in NS for 24 hours at room temperature and when refrigerated at 4 degrees Celsius.
methotrexate (Folex, MTX) (IT CNR available)	Yes	No	Room Temperature	Do Not Prep Syringe on Friday	Yes	Yes	1000 mg/40 mL 250 mg/10 mL 50 mg/2 mL (25 mg/mL)	N/A	Protect vials and dilution from light	NO	Secondary	NO	NO	N/A	NO	50 - 1000 mL NS or D5W IT: 5 - 6 mL PF NS IM: 2 mL per site (if > 2 mL, use multiple syringes) PEDs: Per Protocol	Max 25 mg/mL	IVP: each 10 mg over 1 min. IVPB: ≥30 min or CI over 24 hrs.	25 mg/mL PF Solution	72 hrs IT: 4 hrs IM Syringe: 24 hrs	72 hrs IT: N/A IM Syringe: 24 hrs	Use Preservative-Free NS for intrathecal preparations and for high-dose methotrexate	Add drug into bag (overfill + drug volume) If goes over maximum volume allowance, manipulate during verification to just overfill only	May be administered as slow IVP, bolus infusion, 24 hour continuous infusion, or IM.	1, 3, 4, 8, 13	SDV	May be dispensed in IVPB or syringe.
mirvetuximab soratansine (Elahere)	No	No	N/A	N/A	Yes	No	100mg/20mL (5 mg/mL)	N/A	Protect vials from light	PES in-line 0.2-0.22 micron	Primary PRIME LINE WITH DRUG	NO	NO	Do Not Shake	NO	D5W	1 - 2 mg/mL	Titration	5 mg/mL solution	8 hours	12 hours	Not compatible with NS	Add drug into bag (overfill + drug volume) If goes over maximum volume allowance, manipulate during verification to just overfill only		1, 8	SDV
mitoMYcin (Mutamycin)	No	No	N/A	N/A	Yes	Yes	40 mg 20 mg 5 mg	N/A	Protect vials and dilution from light	Yes for opthalmic preparations	Secondary	NO	NO	N/A	Vesicant	50 mL NS 40 mg/40 mL NS Bladder Irrigation	Undiluted: 0.5 mg/mL Diluted: 0.02 - 0.04 mg/mL	IV Push: 5-10 min IVPB: 15-30 min	5 mg vial + 10 mL SWFI 20 mg vial + 40 mL SWFI 40 mg vial + 80 mL SWFI (Conc: 0.5 mg/mL)	NS: 3 hrs D5W: 3 hrs	24 hrs	Filter eye preps with 0.22 micron filter. Bladder irrigation in syringe 1 mg/mL dilution.	Drug volume, if ever in an IVPB also include overfill and drug volume	Administer as slow IVP via freely-running saline infusion. Also administered intravesically and intra-arterially.	1, 3, 4, 8, 13	SDV	Dispensed in a syringe.
mitoXANTRONE (Novantrone)	No	No	N/A	N/A	Yes	Yes	20 mg/mL 12.5 mg/12.5 mL 30 mg/15 mL (2 mg/mL)	N/A	NO	NO	Secondary	NO	NO	N/A	Irritant with vesicant-like properties	100 mL (at least 50 mL) NS or D5W CI: 1000 mL NS	N/A	IVPB: 15-30 min CI: 24 hrs	2 mg/mL Solution	48 hrs	Protect from light: 7 days	Do not administer IT, SubQ, IM, or intra-arterial.	Add drug into bag (overfill + drug volume)	Usually administered as a short IV infusion over 5 to 15 minutes. Do not infuse over less than 3 to 5 minutes.	1, 2, 3, 4, 8, 19	SDV	syringe
mycophenolate (Cellcept)	No	No	N/A	N/A	No	No	500 mg	Do not refrigerate	NO	NO	Secondary	NO	NO	N/A	NO	1 g: add to 140 mL D5W 1.5 g: add to 210 mL D5W	6 mg/mL	No less than 2 hours	500 mg vial + 14 mL D5W Total Volume = 15 mL (Conc: 33.3 mg/mL)	4 hrs	N/A	Label with gloves/handle carefully sticker. Not compatible with NS.	N/A	Do not administer IV solution by rapid or bolus injection.	1, 8	SDV
nelarabine (Arranon)	No	No	N/A	N/A	Yes	No	250 mg/50 mL (5 mg/mL)	Do Not Refrigerate	NO	NO	Secondary	NO	NO	N/A	NO	Do not dilute	5 mg/mL	Adults: 2 hrs PEDs: 1 hr	5 mg/mL Solution	8 hrs	N/A	Transfer the appropriate dose into empty PVC bag.	Straight drug	Infuse over 2 hours for adults, and 1 hour for peds.	1, 8	SDV	empty bag
omacetaxine (Synribo)	No	No	N/A	N/A	Yes	No	3.5 mg	N/A	Protect from light	NO	N/A	N/A	N/A	Do Not Shake	N/A	N/A	N/A	N/A	3.5 mg vial + 1 mL NS (Conc: 3.5 mg/mL)	12 hrs	6 days	Gently swirl until solution is clear	Straight drug	Administer SubQ	1, 8	SDV	syringe, goes through OSP
oxaliplatin (Eloxatin)	Yes	No	Refrigerated	N/A	Yes	No	200 mg/40 mL 100 mg/20 mL 50 mg/10 mL (5 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant with vesicant-like properties	250 - 500 mL D5W	N/A	2 hrs	5 mg/mL Solution	4 days	10 days	Incompatible with NS.	Add drug into bag (overfill + drug volume)	Administer as IV infusion over 2 hours. Flush line with D5W before and after infusion.	1, 2, 3, 4, 8, 10	SDV
PACLitaxel (Taxol)	Yes	No	Room Temperature	Do Not Prep on Friday	Yes	Yes	300 mg/50 mL 150 mg/25 mL 100 mg/16.7 mL 30 mg/5 mL (6 mg/mL)	N/A	Protect vials from light	0.22 micron inline filter	Primary PRIME LINE WITH DRUG	YES	Non-DEHP Container	N/A	Irritant with vesicant-like properties	250 - 1000 mL NS or D5W	0.3 - 1.2 mg/mL	1-3 hrs CI: 24 hrs	6 mg/mL Solution	24 hrs	N/A	Chemo dispensing pin should not be used to withdraw paclitaxel from vial. Check compatibility with closed system transfer devices.	Remove drug volume and overfill in order to make total volume of 250mL or 500mL	Infuse over 1, 3 or 24 hours. May also be given IP.	1, 2, 3, 4, 8	MDV
PACLitaxel (Protein & Albumin Bound) (Abraxane)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	Yes	100 mg	N/A	Protect from light	DO NOT FILTER	Secondary	NO	NO	Do Not Shake	May be an irritant	Do not dilute	N/A	30-40 min	100 mg vial + 20 mL NS (Conc: 5 mg/mL)	3 hrs	23 hrs	Slowly inject 20 mL of NS onto the INSIDE WALL OF THE VIAL to avoid foaming. Allow the vial to sit for a minimum of 5 min to ensure proper wetting of the lyophilized cake/powder. Gently swirl the vial for at least 2 min until complete dissolution of powder. If foaming or clumping occurs, stand solution for at least 15 min until foam subsides.	Straight drug	Administer IV over 30-40 minutes	1, 8	SDV	empty bag
pamidronate (Aredia)	No	No	N/A	N/A	No	No	90 mg/10 mL (9 mg/mL) 60 mg/10 mL (6 mg/mL) 30 mg/10 mL (3 mg/mL)	Do not refrigerate solution formulation	NO	NO	Secondary	NO	NO	N/A	NO	250 mL - 1000 mL NS or D5W depending upon indication	N/A	2-24 hrs	9 mg/mL, 6 mg/mL, and 3 mg/mL Solution	24 hrs	N/A		N/A	Infusion rates vary by indication.	1, 8	SDV
PEMEtrexed (Alimta)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	Yes	1000 mg 750 mg 500 mg 100 mg	N/A	NO	NO	Secondary	NO	NO	N/A	NO	TV 100 mL NS	N/A	10 min	1000 mg + 40 mL PFNS 750 mg vial + 30 mL PFNS 500 mg vial + 20 mL PFNS 100 mg vial + 4.2 mL PFNS (Conc: 25 mg/mL)	Immediate use	24 hrs	Incompatible in solution containing calcium or LR.	Remove overfill and drug volume in order to make total volume of 100 mL.	Infuse over 10 minutes.	1, 2, 3, 4, 8	SDV
pentostatin (Nipent)	No	No	N/A	N/A	Yes	No	10 mg	N/A	NO	NO	Secondary	NO	NO	N/A	NO	25 - 50 mL NS or D5W	IVP: 2 mg/mL 0.18 - 0.33 mg/mL	IV Push: 5 min IVPB: 20-30 min	10 mg vial + 5 mL SWFI (Conc: 2 mg/mL)	8 hrs	N/A		Add drug into bag (overfill + drug volume)	Administer IV over 20-30 minutes or as a bolus infusion.	1, 4, 7, 8, 10	SDV	May be dispensed in IVPB or syringe.
pertuzumab (Perjeta)	Yes (420 mg maintenance dose only)	No	Refrigerated	Do Not Prep on Friday	Yes	No	420 mg/14 mL (30 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	Do Not Shake	NO	250 mL NS	N/A	840 mg: 60min 420 mg: 30-60 min	30 mg/mL Solution	24 hrs	24 hrs	Mix by gentle inversion. DO NOT SHAKE. Not compatible with D5W.	Add drug into bag (overfill + drug volume)	IV infusion only. Infuse initial dose over 60 minutes, infusion maintenance dose over 30-60 minutes. Do not administer IV push or as a rapid bolus.	1, 3, 8, 14	SDV
pertuzumab/ trastuzumab/ hyaluronidase (Phesgo)	No	No	N/A	N/A	Yes	Yes	1200 mg/600 mg/30,000 units ----------- 600 mg/600 mg/20,000 units	N/A	Protect vials from light	NO	N/A	N/A	N/A	Do Not Shake	N/A	N/A	N/A	Loading dose: 8 min. Maintenance dose: 5 min.	N/A	4 hrs	24 hrs	For subcutaneous use only, do not administer by other routes.	No (syringe)	Subcutaneous only, alternate the injection site between left and right thigh.	1, 8	SDV	Dispensed in a syringe
polatuzumab vedotin (Polivy)	No	No	N/A	N/A	Yes	No	140 mg	N/A	Protect vials from light	0.2 - 0.22 micron	Secondary	NO	NO	Do Not Shake	NO	50 mL NS or D5W (minimum volume)	0.72 - 2.7 mg/mL	Initial dose: 90 min. Subsequent doses: 30 min.	140 mg vial + 7.2 mL SWFI (Conc: 20 mg/mL)	4 hours in NS 6 hours in D5W	24 hrs in NS 36 hours in D5W	Slowly inject 7.2 mL of SWFI onto the INSIDE WALL OF THE VIAL. Swirl gently until completely dissolved. Gently invert bag to mix, limit agitation of dilution.	Add drug into bag (overfill + drug volume)	Administer first infusion over 90 minutes. If tolerated, subsequent infusions may given over 30 minutes.	1, 8	SDV
PRALAtrexate (Folotyn)	No	No	N/A	N/A	Yes	Yes	40 mg/2 mL 20 mg/1 mL (20 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	NO	Do not dilute	N/A	IVP: 3-5 min	20 mg/mL Solution	Use immediately	N/A	Manufacturer recommends immediate use.	Straight drug	IV Push through a side port of free flowing NS.	1, 8	SDV	Dispensed in a syringe
romiDEPsin (Istodax)	No	No	N/A	N/A	Yes	Yes	10 mg	Do Not Refrigerate	Protect from Light	NO	Secondary	NO	NO	N/A	NO	500 mL NS	N/A	4 hrs	10 mg + 2.2 mL supplied diluent (Conc: 5 mg/mL)	24 hrs	N/A	Manufacturer recommends use as soon as possible.	Add drug into bag (overfill + drug volume)	Must be diluted prior to infusion. Infuse over 4 hours.	1, 8	SDV
sacituzumab govitecan (Trodelvy)	No	No	N/A	N/A	Yes	No	180 mg	N/A	Protect vials and infusion from light	NO	Secondary PRIME LINE WITH DRUG	NO	NO	Do Not Shake	NO	TV 500 mL NS for pts weighing <170 kg. Divide dose equally into two 500 mL NS bags for pts weighing > 170 kg.	1.1 - 3.4 mg/mL	Initial dose: 3 hours. Subsequent doses: 1-2 hours.	180 mg vial + 20 mL NS (Conc: 10 mg/mL)	4 hours	24 hours; once removed from the refrigerator must be used within 8 hours including infusion time	Allow vials to come to room temperature prior to reconstitution and dilution. Gently swirl vials and allow to dissolve for up to 15 minutes. Dilute immediately.	Remove overfill and drug volume in order to make total volume of 500 mL.	Administer the initial dose over 3 hours. If well tolerated, may run subsequent infusions over 1-2 hours.	1, 8	SDV
streptozocin (Zanosar)	No	No	N/A	N/A	Yes	No	1000 mg	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Irritant with vesicant-like properties	50 - 250 mL NS or D5W	Max 100 mg/mL	Varies	1000 mg vial + 9.5 mL NS (Conc: 100 mg/mL)	12 hrs	12 hrs		Add drug into bag (overfill + drug volume)	Administer as a rapid IV injection or as short or prolonged infusion.	1, 4, 8	SDV
talimogene laherparepvec (Imlygic)	No	No	N/A	N/A	Yes	No	1 million PFU/mL ----------- 100 million PFU/mL	N/A	Protect vials from light	NO	N/A	N/A	N/A	Do Not Shake	N/A	Do not dilute	N/A	Intralesional injections	1 million PFU/mL ------------ 100 million PFU/mL	1 million PFU: 12 hrs 100 million PFU: 48hrs	1 million PFU: 24 hrs 100 million PFU: 1 week	Store at -80 degree Celsius freezer. Store in the carton until use. Thaw frozen vials at RT until liquid (approx. 30-70 minutes). Swirl gently. Handle carefully - follow biohazard policy.	Straight drug	Inject intralesionally into cutaneous, subcutaneous and/or nodal lesions.	1, 8	SDV	syringe
temozolomide (Temodar)	No	No	N/A	N/A	Yes	No	100 mg	Refrigerate vials. Do not refrigerate dilution.	NO	NO	Secondary	NO	NO	Do Not Shake	NO	Do not dilute	2.5 mg/mL	90 min	100 mg vial + 41 mL SWFI (Conc: 2.5 mg/mL)	14 hrs (including infusion time)	N/A	Bring the vial to RT prior to reconstitution. Gently swirl. Transfer the appropriate dose into empty bag. Must be infused in NS containing line.	Straight drug	Infuse over 90 minutes.	1, 8	SDV	empty 250 mL bag
temsirolimus (Torisel)	No	No	N/A	N/A	Yes	No	25 mg	Refrigerate vials. Do not refrigerate dilution.	Protect vials and dilution from light	0.2-5 micron	Primary	Yes	Non-DEHP Container	Avoid excessive shaking	NO	250 mL NS	N/A	30-60 min	25 mg/mL vial + 1.8 mL supplied diluent (Conc: 10 mg/mL) (stable 24 hrs in vial at RT)	6 hrs after the addition to NS	N/A	Mix well by inversion of the vial. Allow sufficient time for air bubbles to subside.	Add drug into bag (overfill + drug volume)	Infuse over 30-60 minutes,	1, 8	SDV
thiotepa (Tepadina)	No	No	N/A	N/A	Yes	No	15mg 100mg	N/A	Protect vials and dilution from light	0.22 micron syringe filter prior to dilution AND 0.2 micron in-line filter on final product	Secondary	No	No	N/A	Irritant	IVPB: 100 - 10000 mL NS IT: 10 mL PF NS	IVPB: 0.5 - 1 mg/mL	3 hours	15 mg vial + 1.5 mL SWFI (Conc: 10 mg/mL) 100 mg vial + 10 mL SWFI (Conc: 10mg/mL)	Use immediately If not used immediately, stable for 4 hours	Use immediately If not used immediately, stable for 24 hours	Filter through 0.22 micron syringe filter prior to dilution	Add drug into bag (overfill + drug volume)		1, 8	SDV
tisotumab vedotin (Tivdak)	No	No	N/A	N/A	Yes	No	40 mg	N/A	Protect vials and infusion from light	0.2 micron in-line filter	Secondary	NO	NO	Do Not Shake	NO	NS or D5W	0.7 mg/mL to 2.4 mg/mL	30 minutes	40 mg vial + 4 mL SWFI (Conc: 10 mg/mL)	Use immediately	NS: 18 hours D5W: 25 hours	If refrigerated, complete administration of the diluted infusion solution within 4 hours including infusion time.	Add drug into bag (overfill + drug volume)	Infusion over 30 minutes. Do not infuse as IV push or bolus.	1, 8	SDV
topotecan (Hycamtin)	Yes	No	Refrigerated	N/A	Yes	No	4 mg/4 mL (1 mg/mL)	N/A	Protect vials and infusion from light	NO	Secondary	NO	NO	N/A	Irritant	50 - 100 mL NS or D5W	0.01 - 0.5 mg/mL	IVPB: 30 min CI: 24 hrs	1 mg/mL Solution	24 hrs	7 days		Add drug into bag (overfill + drug volume)	Administer IV piggyback over 30 minutes	1, 2, 3, 4, 10	SDV
trabectedin (Yondelis)	No	No	N/A	N/A	Yes	No	1 mg	N/A	NO	0.2 micron in-line filter	Secondary	NO	NO	N/A	Vesicant	NS or D5W	N/A	IVPB: 3 hours CI: 24 hrs	1 mg + 20 mL SWFI (Conc: 0.05 mg/mL)	30 hours including infusion time	N/A	Infusion must be completed within 30 hours of reconstitution.	Add drug into bag (overfill + drug volume)	Infuse as a continuous infusion over 24 hours, off-label as IVPB over 3 hours.	1, 8	SDV
vinBLAStine (Velban)	Yes	No	Refrigerated	N/A	Yes	Yes	10 mg/10 mL (1 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Vesicant	25-50 mL NS IVPB	Max 1 mg/mL	IVPB: 15 min	1 mg/mL Solution	24 hrs	7 days	FATAL IF GIVEN INTRATHECALLY	Add drug into bag (overfill + drug volume)	Administer in IVPB only and give as a short infusion.	1, 2, 3, 4, 8	MDV
vinCRIStine (Oncovin)	Yes	No	Refrigerated	N/A	Yes	Yes	2 mg/2 mL 1 mg/mL (1mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Vesicant	25-50 mL NS IVPB	0.0015 - 0.08 mg/mL	IVPB: 15 min	1 mg/mL Solution	48 hrs	5 days	FATAL IF GIVEN INTRATHECALLY	Add drug into bag (overfill + drug volume)	Administer in IVPB only and give as a short infusion.	1, 2, 3, 4, 8	SDV
vinorelbine (Navelbine)	Yes	No	Refrigerated	Do Not Prep on Friday	Yes	No	50 mg/5 mL (10 mg/mL)	N/A	Protect vials from light	NO	Secondary	NO	NO	N/A	Vesicant	25-50 mL NS IVPB	0.5 - 2 mg/mL	IVPB: 6-10 min	10 mg/mL Solution	24 hrs	24 hrs	FATAL IF GIVEN INTRATHECALLY	Add drug into bag (overfill + drug volume)	Administer IVPB only over 6-10 minutes, followed by at least 75 mL compatible IV solution.	1, 2, 3, 4, 8	SDV
ziv-aflibercept (Zaltrap)	No	No	N/A	N/A	Yes	No	200 mg/8 mL 100 mg/4 mL (25 mg/ mL)	N/A	Protect vials from light	0.2 micron polyether sulfone filter	Secondary	NO	NO	N/A	NO	NS or D5W	0.6-8 mg/mL	1 hour	25 mg/mL Solution	8 hrs	24 hrs	After initial vial puncture, do not re-enter vial.	Add drug into bag (overfill + drug volume)	Infuse over 1 hour. Do not administer as an IV push or bolus.	1, 8	SDV
zoledronic acid (Zometa)	No	Yes	Refrigerated	Do Not Prep on Friday	No	No	4mg/5 mL (0.8 mg/mL)	N/A	NO	NO	Secondary	NO	NO	N/A	NO	100 mL NS or D5W	N/A	15 minutes	0.8 mg/mL Solution	Immediate Use	23 hrs	Do not mix with calcium containing solutions. If refrigerated, allow to come to room temperature prior to administration.	N/A	Infuse over at least 15 minutes	1, 8	SDV
EPOCH (vincCRIStine, DOXOrubicin, etoposide)	No	No	N/A	N/A	Yes	Yes	see individual components	N/A	See individual components; Protect dilution from light	NO	Primary	YES	Non-DEHP Container	Do Not Shake	Vesicant	Etoposide </= 125mg: 500 mL NS Etoposide > 125mg: 1000 mL NS	Vincristine: 0.001-0.002 mg/mL Doxorubicin: 0.025-0.05 mg/mL Etoposide: </= 0.25 mg/mL	CI: 24 hrs	See individual components	36 hrs	N/A	EPOCH bags can ONLY be safely given over 24 hours. No extended infusion bags.	Remove overfill and drug volume in order to make total volume of 500 or 1000 mL.	Infuse as a continuous infusion over 24 hours	6, 8	See individual components
HIPEC (CISplatin & DOXOrubicin)						yes			Light Protected				Exactamix Container			IP: 2000 mL Dianeal Low Calcium 1.5% (Dialysis Solution) Transferred to Exactamix Bag		90 min		24 hrs		Transfer contents of peritoneal dialysis solution to an empty Exactamix bag before adding chemo drugs. Overfill and volume of drug added are not removed. No tubing is attached to bag. No spiros cap is attached to bag. Add “Not for IV Use” Label.			17
HIPEC (mitoMYcin & DOXOrubicin)						No			Light Protected				Exactamix Container			IP: 2000 mL Dianeal Low Calcium 1.5% (Dialysis Solution) Transferred to Exactamix Bag		90 min		24 hrs		Transfer contents of peritoneal dialysis solution to an empty Exactamix bag before adding chemo drugs. Overfill and volume of drug added are not removed. No tubing is attached to bag. No spiros cap is attached to bag. Add “Not for IV Use” Label.			17
HIPEC (melphalan)						No							Exactamix Container			IP: 2000 mL Dianeal Low Calcium 1.5% (Dialysis Solution) Transferred to Exactamix Bag		60 min		Complete w/in 1 hr of reconstitution	N/A	Transfer contents of peritoneal dialysis solution to an empty Exactamix bag before adding chemo drugs. Overfill and volume of drug added are not removed. No tubing is attached to bag. No spiros cap is attached to bag. Add “Not for IV Use” Label. Prepare as close to the administration time as possible (less than 15 minutes preparation and delivery time). MUST DOCUMENT IN MELPHALAN BINDER.			17

** add reuse to sterile products policy - column Q

** issue - prep site - and HL7 - field is only 5 characters in CATO - disp prep location Epic is in RXE 40 - Ginger

prep site - interim pick defaults to prep site 1 - PS1 - all use this

** storage will need to be the same - 797 - ISO 5 - compounding - made in hood; use CSTD - so microbial is 2 weeks. if e.g. bendamustine - Treanda is 1 x use; Bendeka - multidose vial. Picks the lesser of 2 #s so if remainder of the med, then that is what shows for the remainder. so have to put chemical because shorter

also change fluid name a bit… error; universal BUD - Joe

** UID=Med ID, not Epic ERX (conc level) - product in general unless talking about a specific vial size; then need med ID if more than 1 vial size. HL7 interface - Med ID comes through

e.g. amiodarone - central vs peripheral; low-rate syringes 3mL vs 50mL syringe and we have 2 Med ID - so have to build both of these. So, name will have to be discreet as well and in this case is it 4 products? ==>

**BOP labeling rules re: generic vs Brand - Angie -

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.